To elucidate the underlying mechanisms of MLT-Gel@HC-EA treatment in RA, we investigated the NF-κB, AKT, and IL-1β expression levels using immunofluorescence (Table S9, Fig. 7-c, Figure S5). The gene discussed is IL1B; the disease is rheumatoid arthritis.